Search by Drug Name or NDC

    NDC 63824-0671-20 Mucinex Childrens 5; 100; 2.5 mg/1; mg/1; mg/1 Details

    Mucinex Childrens 5; 100; 2.5 mg/1; mg/1; mg/1

    Mucinex Childrens is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63824-0671
    Product ID 63824-671_1d3f7456-7311-4f85-b811-2d60c604063a
    Associated GPIs 43997303100301
    GCN Sequence Number 080836
    GCN Sequence Number Description guaifen/dextromethorphan/PE TABLET 100-5-2.5 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 47817
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Brand
    Proprietary Name Mucinex Childrens
    Proprietary Name Suffix Cough and Congestion
    Non-Proprietary Name dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 5; 100; 2.5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name RB Health (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 63824-0671-20 (63824067120)

    NDC Package Code 63824-671-20
    Billing NDC 63824067120
    Package 1 BLISTER PACK in 1 CARTON (63824-671-20) / 20 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2019-04-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 94526b83-c124-476b-8af8-8656ad5ed431 Details

    Revised: 12/2021